izpis_h1_title_alt

Glucocorticoid receptor regulates TNFSF11 transcription by binding to glucocorticoid responsive element in TNFSF11 proximal promoter region
ID Lovšin, Nika (Author), ID Marc, Janja (Author)

.pdfPDF - Presentation file, Download (10,26 MB)
MD5: EF4EFD4805341069BD2F4FA1C19F36E4
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/22/3/1054 This link opens in a new window

Abstract
Glucocorticoid osteoporosis is a serious side effect of long term glucocorticoid uptake and it is caused by osteoblast apoptosis and imbalance in the major bone remodeling pathway RANK/RANKL/OPG. The impact of glucocorticoid on the maintenance of RANK/RANKL/OPG is well explored; dexamethasone was shown to disturb the ratio between OPG and RANKL level by decreasing the expression level of OPG and increasing level of RANKL. Here, were aimed to decipher whether glucocorticoid receptor directly influences RANKL promoter activity and its transcriptional regulation. We demonstrate that overexpression of glucocorticoid receptor (GR) NR3C1 increased RANKL promoter activity in human osteosarcoma, cervical cancer (2-fold) and adenocarcinoma cells (4.5-fold). Mutational analysis revealed that +352 site in the RANKL promoter is functional glucocorticoid responsive element (GRE) since the effect of GR on RANKL promoter activity was diminished by mutation at this site. Overexpression of NR3C1 upregulated RANKL mRNA expression 1.5-fold in human A549 and HOS cells. On the other hand silencing of NR3C1 caused slight decrease in RANKL mRNA level, suggesting that NR3C1 directly accounts for RANKL transcriptional regulation. Using electrophoretic mobility shift assay we demonstrate that NR3C1 binds to the proximal RANKL promoter region. Our study provides evidences that NR3C1 directly upregulates RANKL transcription in human cell lines and connects the missing link in the mechanism of RANK/RANKL/OPG imbalance of glucocorticoid induced osteoporosis.

Language:English
Keywords:glucocorticoid receptor, NR3C1, RANKL, TNFSF11, glucocorticoid induced osteoporosis
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:14 str.
Numbering:Vol. 22, iss. 3, art. 1054
PID:20.500.12556/RUL-134958 This link opens in a new window
UDC:616-074:616.71-007.234
ISSN on article:1422-0067
DOI:10.3390/ijms22031054 This link opens in a new window
COBISS.SI-ID:48192003 This link opens in a new window
Publication date in RUL:14.02.2022
Views:406
Downloads:106
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.02.2021

Secondary language

Language:Slovenian
Keywords:glukokortikoidni receptorji, osteoporoza, klinična kemija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-7245
Name:Odkrivanje novih regulatorjev izražanja RANKL, ključne molekule ne samo v kostni prenovi

Funder:ARRS - Slovenian Research Agency
Project number:J3-1759
Name:Celostna karakterizacija zadetkov analiz GWAS - pot do novih terapevtskih tarč za anabolno zdravljenje osteoporoze (GWASforAna)

Funder:ARRS - Slovenian Research Agency
Project number:P3-0298
Name:Geni, hormonske in osebnostne spremembe pri metabolnih motnjah

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back